A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer

The time between the last cycle of chemotherapy and recurrence, the platinum-free interval (PFI), predicts overall survival in high-grade serous ovarian cancer (HGSOC). To identify secreted proteins associated with a shorter PFI, we utilized machine learning to predict the PFI from ascites compositi...

Full description

Bibliographic Details
Main Authors: Molly J. Carroll, Katja Kaipio, Johanna Hynninen, Olli Carpen, Sampsa Hautaniemi, David Page, Pamela K. Kreeger
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/17/4291
_version_ 1797496014379155456
author Molly J. Carroll
Katja Kaipio
Johanna Hynninen
Olli Carpen
Sampsa Hautaniemi
David Page
Pamela K. Kreeger
author_facet Molly J. Carroll
Katja Kaipio
Johanna Hynninen
Olli Carpen
Sampsa Hautaniemi
David Page
Pamela K. Kreeger
author_sort Molly J. Carroll
collection DOAJ
description The time between the last cycle of chemotherapy and recurrence, the platinum-free interval (PFI), predicts overall survival in high-grade serous ovarian cancer (HGSOC). To identify secreted proteins associated with a shorter PFI, we utilized machine learning to predict the PFI from ascites composition. Ascites from stage III/IV HGSOC patients treated with neoadjuvant chemotherapy (NACT) or primary debulking surgery (PDS) were screened for secreted proteins and Lasso regression models were built to predict the PFI. Through regularization techniques, the number of analytes used in each model was reduced; to minimize overfitting, we utilized an analysis of model robustness. This resulted in models with 26 analytes and a root-mean-square error (RMSE) of 19 days for the NACT cohort and 16 analytes and an RMSE of 7 days for the PDS cohort. High concentrations of MMP-2 and EMMPRIN correlated with a shorter PFI in the NACT patients, whereas high concentrations of uPA Urokinase and MMP-3 correlated with a shorter PFI in PDS patients. Our results suggest that the analysis of ascites may be useful for outcome prediction and identified factors in the tumor microenvironment that may lead to worse outcomes. Our approach to tuning for model stability, rather than only model accuracy, may be applicable to other biomarker discovery tasks.
first_indexed 2024-03-10T01:57:40Z
format Article
id doaj.art-32e2d3fc0cb1487197ba6b38fcd96acd
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T01:57:40Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-32e2d3fc0cb1487197ba6b38fcd96acd2023-11-23T12:53:04ZengMDPI AGCancers2072-66942022-09-011417429110.3390/cancers14174291A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian CancerMolly J. Carroll0Katja Kaipio1Johanna Hynninen2Olli Carpen3Sampsa Hautaniemi4David Page5Pamela K. Kreeger6Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, USAResearch Center for Cancer, Infections and Immunity, Institute of Biomedicine, University of Turku, FI-20014 Turku, FinlandDepartment of Obstetrics and Gynecology, Turku University Hospital and University of Turku, FI-20014 Turku, FinlandResearch Center for Cancer, Infections and Immunity, Institute of Biomedicine, University of Turku, FI-20014 Turku, FinlandResearch Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, FI-00014 Helsinki, FinlandDepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC 27710, USADepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, USAThe time between the last cycle of chemotherapy and recurrence, the platinum-free interval (PFI), predicts overall survival in high-grade serous ovarian cancer (HGSOC). To identify secreted proteins associated with a shorter PFI, we utilized machine learning to predict the PFI from ascites composition. Ascites from stage III/IV HGSOC patients treated with neoadjuvant chemotherapy (NACT) or primary debulking surgery (PDS) were screened for secreted proteins and Lasso regression models were built to predict the PFI. Through regularization techniques, the number of analytes used in each model was reduced; to minimize overfitting, we utilized an analysis of model robustness. This resulted in models with 26 analytes and a root-mean-square error (RMSE) of 19 days for the NACT cohort and 16 analytes and an RMSE of 7 days for the PDS cohort. High concentrations of MMP-2 and EMMPRIN correlated with a shorter PFI in the NACT patients, whereas high concentrations of uPA Urokinase and MMP-3 correlated with a shorter PFI in PDS patients. Our results suggest that the analysis of ascites may be useful for outcome prediction and identified factors in the tumor microenvironment that may lead to worse outcomes. Our approach to tuning for model stability, rather than only model accuracy, may be applicable to other biomarker discovery tasks.https://www.mdpi.com/2072-6694/14/17/4291ovarian cancerascitesLassoplatinum-free intervalmodel stabilityrobustness
spellingShingle Molly J. Carroll
Katja Kaipio
Johanna Hynninen
Olli Carpen
Sampsa Hautaniemi
David Page
Pamela K. Kreeger
A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer
Cancers
ovarian cancer
ascites
Lasso
platinum-free interval
model stability
robustness
title A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer
title_full A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer
title_fullStr A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer
title_full_unstemmed A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer
title_short A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer
title_sort subset of secreted proteins in ascites can predict platinum free interval in ovarian cancer
topic ovarian cancer
ascites
Lasso
platinum-free interval
model stability
robustness
url https://www.mdpi.com/2072-6694/14/17/4291
work_keys_str_mv AT mollyjcarroll asubsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT katjakaipio asubsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT johannahynninen asubsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT ollicarpen asubsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT sampsahautaniemi asubsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT davidpage asubsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT pamelakkreeger asubsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT mollyjcarroll subsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT katjakaipio subsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT johannahynninen subsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT ollicarpen subsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT sampsahautaniemi subsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT davidpage subsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer
AT pamelakkreeger subsetofsecretedproteinsinascitescanpredictplatinumfreeintervalinovariancancer